Ask AI
ProCE Banner Activity

Current State of Sjögren’s Disease: What HCPs Must Know

Clinical Thought

Learn more about the current landscape for diagnosing, classifying, and treating Sjögren’s disease as well as what persistent gaps must be addressed to improve patient outcomes.

Released: January 26, 2026

Continue Activity View Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Smart Patients.

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Partners

Smart Patients

ProCE Banner

Target Audience

This activity is intended for rheumatologists, nurses, nurse practitioners, and physician associates, who care for patients with Sjögren’s disease. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Assess quality of life and disease burden in patients living with Sjögren’s disease

  • Educate patients with Sjögren’s about the systemic nature of the disease

  • Characterize unmet treatment needs of people living with Sjögren’s disease

  • Differentiate emerging targeted therapies for Sjögren’s disease, including the mechanism of action and recent safety and efficacy data

Disclosure

Primary Author

Nancy Carteron, MD, FACR

Consultant Rheumatologist
Interdisciplinary Sjogren’s Clinic
Clinical Health Sciences Professor
Herbert Wertheim School of Optometry & Vision Science
University of California, Berkeley
Clinical Professor of Medicine (Volunteer)
Division of Rheumatology
University of California, San Francisco
San Francisco, California

Nancy Carteron, MD, FACR: independent contractor: Bristol Myers Squibb, MJH Life Sciences.